Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - December 11, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") On December 8, 2025 Biosenta has entered into a Field Test and Research Agreement with Livespace Homes to evaluate the real-world performance of Biosenta's proprietary antimicrobial nanoparticle technology in a residential construction environment. Under the agreement, the nanoparticles will be incorporated into building materials and/or coatings used in two (2) of the four (4) units of a Livepace four-plex project, enabling side-by-side comparison to evaluate how the technology performs on selected interior surfaces and materials supporting an applied efficacy assessment in the field.
Two of four units in Livespace four-plex will incorporate Biosenta's proprietary nanoparticle technology to enable materials to generate real-world antimicrobial performance data and support commercialization
Livespace Homes project rendering (conceptual). Two units will incorporate Biosenta's antimicrobial nanoparticle technology to enable materials for comparative field evaluation. (CNW Group/Biosenta Inc.)
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/2588/277767_c5bf415234b17b8f_001full.jpg
The field test will allow Biosenta to move from known lab results to practical commercial applications by confirming how well Biosenta's nanoparticle technology performs when applied to selected surfaces and materials in a real residential setting. The goal is to generate field data on performance and durability that can support commercialization planning, partner discussions, and future scaling opportunities.
"People want homes that feel clean and safe," said Am Gill, President and CEO of Biosenta. "Our technology is designed to help protect surfaces from bacteria and mold, so families can worry less about what they cannot see."
Gurpreet Gill, President, Livespace Homes, added: "We're always looking for practical innovations that can improve the performance and livability of the spaces we build. To our knowledge, this is a first-of-its-kind field test in a live multi-unit build, allowing us to evaluate Biosenta's antimicrobial nanotechnology in real conditions and learn what it could mean for residential construction."
The Companies expect the field test to produce structured observations and data that can help inform next steps for product development, partner engagement, and broader market adoption.
About Biosenta Inc.
Biosenta Inc. develops innovative antimicrobial products that offer environmentally friendly solutions to a global market. Based in Toronto, Ontario and Calgary, Alberta, the company is dedicated to the advancement of technology that combats microbial growth in various materials. Biosenta's proprietary nanoparticle represents a breakthrough in antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi.
For further inquiries, please contact:
Am Gill, President and CEO, Biosenta Inc.
Email: info@biosenta.com
Phone: 416-410-2019
For more information, visit our website: www.biosenta.com
Forward-Looking Statements
This press release contains forward-looking information within the meaning of applicable securities laws ("forward-looking statements"), including forward-looking statements relating the completion of the Transaction. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. If any such risks actually occur, they could impact the potential for discussion, agreement or completion of the Transaction and/or materially adversely affect the Company's business, financial condition or results of operations. In that case, the trading price of the Company's common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Disclaimer
The CSE has in no way passed upon the contents of this news release and further, has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277767
Two of four units in Livespace four-plex will incorporate Biosenta's proprietary nanoparticle technology to enable materials to generate real-world antimicrobial performance data and support commercialization
Livespace Homes project rendering (conceptual). Two units will incorporate Biosenta's antimicrobial nanoparticle technology to enable materials for comparative field evaluation. (CNW Group/Biosenta Inc.)
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/2588/277767_c5bf415234b17b8f_001full.jpg
The field test will allow Biosenta to move from known lab results to practical commercial applications by confirming how well Biosenta's nanoparticle technology performs when applied to selected surfaces and materials in a real residential setting. The goal is to generate field data on performance and durability that can support commercialization planning, partner discussions, and future scaling opportunities.
"People want homes that feel clean and safe," said Am Gill, President and CEO of Biosenta. "Our technology is designed to help protect surfaces from bacteria and mold, so families can worry less about what they cannot see."
Gurpreet Gill, President, Livespace Homes, added: "We're always looking for practical innovations that can improve the performance and livability of the spaces we build. To our knowledge, this is a first-of-its-kind field test in a live multi-unit build, allowing us to evaluate Biosenta's antimicrobial nanotechnology in real conditions and learn what it could mean for residential construction."
The Companies expect the field test to produce structured observations and data that can help inform next steps for product development, partner engagement, and broader market adoption.
About Biosenta Inc.
Biosenta Inc. develops innovative antimicrobial products that offer environmentally friendly solutions to a global market. Based in Toronto, Ontario and Calgary, Alberta, the company is dedicated to the advancement of technology that combats microbial growth in various materials. Biosenta's proprietary nanoparticle represents a breakthrough in antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi.
For further inquiries, please contact:
Am Gill, President and CEO, Biosenta Inc.
Email: info@biosenta.com
Phone: 416-410-2019
For more information, visit our website: www.biosenta.com
Forward-Looking Statements
This press release contains forward-looking information within the meaning of applicable securities laws ("forward-looking statements"), including forward-looking statements relating the completion of the Transaction. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. If any such risks actually occur, they could impact the potential for discussion, agreement or completion of the Transaction and/or materially adversely affect the Company's business, financial condition or results of operations. In that case, the trading price of the Company's common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Disclaimer
The CSE has in no way passed upon the contents of this news release and further, has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277767
